Fanimoghadam Hamidreza, Dekamin Mohammad G, Naimi-Jamal M Reza
Pharmaceutical and Heterocyclic Compounds Research Laboratory, Department of Chemistry, Iran University of Science and Technology Tehran 16846-13114 Iran
Nanoscale Adv. 2025 May 19. doi: 10.1039/d5na00224a.
In this study, a new periodic mesoporous organosilica (PMO) functionalized with -aminobenzenesulfonic acid (PABSA) was prepared a novel co-condensation and sequential integration strategy. The obtained periodic mesoporous organosilica (PABSA-Pr-PMO) nanomaterial was characterized using various techniques, including Fourier-transform infrared (FT-IR) spectroscopy, field emission scanning electron microscopy (FESEM), thermogravimetric/differential thermogravimetry analysis (TGA/DTA), the Brunauer-Emmett-Teller (BET) analysis, energy-dispersive X-ray spectroscopy (EDS), EDS elemental mapping, and X-ray diffraction (XRD). The thermally stable PABSA-Pr-PMO nanomaterial demonstrates high surface area, uniform particle size and well-defined active site as a solid acid. This material was successfully employed as an efficient catalyst for the synthesis of pharmaceutically relevant tetrazole derivatives a cascade condensation and concerted 1,3-cycloaddition reaction. The desired 5-substituted 1-tetrazole derivatives were efficiently synthesized through multicomponent reactions between aromatic aldehydes, malononitrile and sodium azide in the presence of PABSA-Pr-PMO in EtOH under reflux conditions. The protocol exhibited excellent yields and high purity. Low catalyst loading, short reaction times, and the use of environmentally friendly solvents such as EtOH and water, which replace the hazardous dimethylformamide (DMF) solvent, are significant advantages of this novel protocol. Additionally, the straightforward separation and recyclability of the catalyst, which maintains its activity for at least five consecutive runs without significant loss, contribute to its robustness and sustainability. This protocol can be distinguished by its efficiency, environmental friendliness, and sustained catalytic activity, highlighting it as an ideal method for the synthesis of 5-substituted 1-tetrazole derivatives.
在本研究中,通过一种新型的共缩聚和顺序整合策略制备了一种用对氨基苯磺酸(PABSA)功能化的新型周期性介孔有机硅(PMO)。使用多种技术对所得的周期性介孔有机硅(PABSA-Pr-PMO)纳米材料进行了表征,包括傅里叶变换红外(FT-IR)光谱、场发射扫描电子显微镜(FESEM)、热重/差示热重分析(TGA/DTA)、布鲁诺尔-埃米特-泰勒(BET)分析、能量色散X射线光谱(EDS)、EDS元素映射和X射线衍射(XRD)。热稳定的PABSA-Pr-PMO纳米材料具有高比表面积、均匀的粒径和明确的活性位点,可作为固体酸。该材料成功地用作合成药学相关四唑衍生物的高效催化剂,用于级联缩合和协同1,3-环加成反应。在回流条件下,在乙醇中,在PABSA-Pr-PMO存在下,通过芳香醛、丙二腈和叠氮化钠之间的多组分反应,高效地合成了所需的5-取代-1-四唑衍生物。该方案具有优异的产率和高纯度。低催化剂负载量、短反应时间以及使用乙醇和水等环境友好型溶剂替代危险的二甲基甲酰胺(DMF)溶剂是该新方案的显著优点。此外,催化剂的直接分离和可回收性,使其至少能连续五次保持活性而无明显损失,这有助于其稳定性和可持续性。该方案具有高效、环境友好和持续催化活性的特点,是合成5-取代-1-四唑衍生物的理想方法。